7. Genito-Urinary System - guidance
To access BNF Formulary section click on the link under BNF Section/s
To access the Guidance Document click on the highlighted text under the Title column
Use documents past their review date with Caution
| BNF Section/s | Title | Issuing Body | Date of Issue | Update Due |
| 7.1.1/7.1.1.1 | Over Active Bladder - Primary Care Management of Overactive Bladder (OAB) In Women Version 8 | Kent & Medway ICB | Oct 2023 | Oct 2025 |
| 7.3.3 | Ulipristal Acetate - Update: Class 2 Medicines Recall: Esmya 5mg tablets |
MHRA Drug Safety Update |
Feb 2021 | - |
| 7.4.1 | Erectile Dysfunction - Drugs And Devices Used In The Treatment Of Erectile Dysfunction | MFT / Medway & Swale CCG | Nov 2014 |
Oct 2016
|
| 7.4.2 | Premature Ejaculation - Dapoxetine for premature ejaculation (PE) | Kent & Medway CCG PRGC | Jun 2014 | |
| 7.5.5 | Uterine Fibroids - Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids TA832 | NICE | Oct 2022 |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only